Company profile for Rubicon Research

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Rubicon Research is a pioneer Drug Delivery Technology company based in India with significant experience in the field of formulation development. Rubicon has developed many differentiated products which are protected by patents and are available for out licensing. Rubicon also provides a full spectrum of development services from pre-formulation to registration.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
India
Address
Address
221,Annexe Building ,Goregaon-Mulund Link Road,
Telephone
Telephone
91 226 141 4000
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

PEGS Boston Summit

PEGS Boston Summit

Not Confirmed

envelop Contact Supplier

PEGS Boston Summit

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216988

FDA
21 May 2026

https://www.pharmiweb.com/press-release/2026-04-21/gen1e-and-rubicon-research-announce-strategic-partnership-to-advance-ai-driven-precision-immunomodul

PHARMIWEB
21 Apr 2026

https://www.indianpharmapost.com/news/rubicon-forays-into-indias-cns-segment-with-rs-17592-crore-arinna-buy-19755

INDPHARMAPOST
16 Apr 2026

https://www.expresspharma.in/rubicon-research-acquires-85-stake-in-arinna-lifesciences/

EXPRESSPHARMA
15 Apr 2026

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220239

FDA
05 Mar 2026

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220335

FDA
25 Feb 2026

Drugs in Development

read-more
read-more

Details:

Under the acquisition of Sodium Valproate, the deal aims to advance CNS disorder treatments through targeting HDAC and GABA.


Lead Product(s): Sodium Valproate,Divalproex Sodium

Therapeutic Area: Neurology Brand Name: Amvalor Chrono

Study Phase: Approved FDFProduct Type: Miscellaneous

Recipient: Arinna Lifesciences

Deal Size: $1.8 million Upfront Cash: Undisclosed

Deal Type: Acquisition April 16, 2026

blank

01

PEGS Boston Summit
Not Confirmed
PEGS Boston Summit
Not Confirmed

Details : Under the acquisition of Sodium Valproate, the deal aims to advance CNS disorder treatments through targeting HDAC and GABA.

Product Name : Amvalor Chrono

Product Type : Miscellaneous

Upfront Cash : Undisclosed

April 16, 2026

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Brand Name : ACETAZOLAMIDE

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : ACETAZOLAMIDE

arrow
PEGS Boston Summit
Not Confirmed

Rubicon Research

Dosage Form : TABLET;ORAL

Brand Name : ACETAZOLAMIDE

Dosage Strength : 125MG

Packaging :

Approval Date : 2021-08-19

Application Number : 215101

Regulatory Info : RX

Registration Country : USA

blank

02

Brand Name : ACETAZOLAMIDE

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : ACETAZOLAMIDE

arrow
PEGS Boston Summit
Not Confirmed

Rubicon Research

Dosage Form : TABLET;ORAL

Brand Name : ACETAZOLAMIDE

Dosage Strength : 250MG

Packaging :

Approval Date : 2021-08-19

Application Number : 215101

Regulatory Info : RX

Registration Country : USA

blank

03

Brand Name : ACYCLOVIR

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : ACYCLOVIR

arrow
PEGS Boston Summit
Not Confirmed

Rubicon Research

Dosage Form : SUSPENSION;ORAL

Brand Name : ACYCLOVIR

Dosage Strength : 200MG/5ML

Packaging :

Approval Date : 2022-08-18

Application Number : 215724

Regulatory Info : RX

Registration Country : USA

blank

04

Brand Name : AMANTADINE HYDROCHLO...

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : AMANTADINE HYDROCHLO...

arrow
PEGS Boston Summit
Not Confirmed

Rubicon Research

Dosage Form : CAPSULE;ORAL

Brand Name : AMANTADINE HYDROCHLORIDE

Dosage Strength : 100MG

Packaging :

Approval Date : 2020-05-21

Application Number : 212044

Regulatory Info : RX

Registration Country : USA

blank

05

Brand Name : AMIODARONE HYDROCHLO...

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : AMIODARONE HYDROCHLO...

arrow
PEGS Boston Summit
Not Confirmed

Rubicon Research

Dosage Form : TABLET;ORAL

Brand Name : AMIODARONE HYDROCHLORIDE

Dosage Strength : 200MG

Packaging :

Approval Date : 2008-11-06

Application Number : 78578

Regulatory Info : RX

Registration Country : USA

blank

06

Brand Name : AMIODARONE HYDROCHLO...

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : AMIODARONE HYDROCHLO...

arrow
PEGS Boston Summit
Not Confirmed

Rubicon Research

Dosage Form : TABLET;ORAL

Brand Name : AMIODARONE HYDROCHLORIDE

Dosage Strength : 100MG

Packaging :

Approval Date : 2021-02-26

Application Number : 78578

Regulatory Info : RX

Registration Country : USA

blank

07

Brand Name : AMIODARONE HYDROCHLO...

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : AMIODARONE HYDROCHLO...

arrow
PEGS Boston Summit
Not Confirmed

Rubicon Research

Dosage Form : TABLET;ORAL

Brand Name : AMIODARONE HYDROCHLORIDE

Dosage Strength : 400MG

Packaging :

Approval Date : 2021-02-26

Application Number : 78578

Regulatory Info : RX

Registration Country : USA

blank

08

Brand Name : AMITRIPTYLINE HYDROC...

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : AMITRIPTYLINE HYDROC...

arrow
PEGS Boston Summit
Not Confirmed

Rubicon Research

Dosage Form : TABLET;ORAL

Brand Name : AMITRIPTYLINE HYDROCHLORI...

Dosage Strength : 10MG

Packaging :

Approval Date : 2023-05-01

Application Number : 215376

Regulatory Info : RX

Registration Country : USA

blank

09

Brand Name : AMITRIPTYLINE HYDROC...

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : AMITRIPTYLINE HYDROC...

arrow
PEGS Boston Summit
Not Confirmed

Rubicon Research

Dosage Form : TABLET;ORAL

Brand Name : AMITRIPTYLINE HYDROCHLORI...

Dosage Strength : 25MG

Packaging :

Approval Date : 2023-05-01

Application Number : 215376

Regulatory Info : RX

Registration Country : USA

blank

10

Brand Name : AMITRIPTYLINE HYDROC...

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : AMITRIPTYLINE HYDROC...

arrow
PEGS Boston Summit
Not Confirmed

Rubicon Research

Dosage Form : TABLET;ORAL

Brand Name : AMITRIPTYLINE HYDROCHLORI...

Dosage Strength : 50MG

Packaging :

Approval Date : 2023-05-01

Application Number : 215376

Regulatory Info : RX

Registration Country : USA

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

Brand Name : ACETAZOLAMIDE

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : ACETAZOLAMIDE

PEGS Boston Summit
Not Confirmed
arrow

Rubicon Research

Dosage Form : TABLET; ORAL

Proprietary Name : ACETAZOLAMIDE

Dosage Strength : 125MG

Approval Date : 2021-08-19

Application Number : 215101

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

02

Brand Name : ACETAZOLAMIDE

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : ACETAZOLAMIDE

PEGS Boston Summit
Not Confirmed
arrow

Rubicon Research

Dosage Form : TABLET; ORAL

Proprietary Name : ACETAZOLAMIDE

Dosage Strength : 250MG

Approval Date : 2021-08-19

Application Number : 215101

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

03

Brand Name : ACYCLOVIR

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : ACYCLOVIR

PEGS Boston Summit
Not Confirmed
arrow

Rubicon Research

Dosage Form : SUSPENSION; ORAL

Proprietary Name : ACYCLOVIR

Dosage Strength : 200MG/5ML

Approval Date : 2022-08-18

Application Number : 215724

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

04

Brand Name : AMANTADINE HYDROCHLO...

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : AMANTADINE HYDROCHLO...

PEGS Boston Summit
Not Confirmed
arrow

Rubicon Research

Dosage Form : CAPSULE; ORAL

Proprietary Name : AMANTADINE HYDROCHLORIDE

Dosage Strength : 100MG

Approval Date : 2020-05-21

Application Number : 212044

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

05

Brand Name : AMIODARONE HYDROCHLO...

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : AMIODARONE HYDROCHLO...

PEGS Boston Summit
Not Confirmed
arrow

Rubicon Research

Dosage Form : TABLET; ORAL

Proprietary Name : AMIODARONE HYDROCHLORIDE

Dosage Strength : 200MG

Approval Date : 2008-11-06

Application Number : 78578

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

06

Brand Name : AMIODARONE HYDROCHLO...

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : AMIODARONE HYDROCHLO...

PEGS Boston Summit
Not Confirmed
arrow

Rubicon Research

Dosage Form : TABLET; ORAL

Proprietary Name : AMIODARONE HYDROCHLORIDE

Dosage Strength : 100MG

Approval Date : 2021-02-26

Application Number : 78578

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

07

Brand Name : AMIODARONE HYDROCHLO...

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : AMIODARONE HYDROCHLO...

PEGS Boston Summit
Not Confirmed
arrow

Rubicon Research

Dosage Form : TABLET; ORAL

Proprietary Name : AMIODARONE HYDROCHLORIDE

Dosage Strength : 400MG

Approval Date : 2021-02-26

Application Number : 78578

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

08

Brand Name : AMITRIPTYLINE HYDROC...

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : AMITRIPTYLINE HYDROC...

PEGS Boston Summit
Not Confirmed
arrow

Rubicon Research

Dosage Form : TABLET; ORAL

Proprietary Name : AMITRIPTYLINE HYDROCHLOR...

Dosage Strength : 10MG

Approval Date : 2023-05-01

Application Number : 215376

RX/OTC/DISCN : RX

RLD : No

TE Code : BX

blank

09

Brand Name : AMITRIPTYLINE HYDROC...

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : AMITRIPTYLINE HYDROC...

PEGS Boston Summit
Not Confirmed
arrow

Rubicon Research

Dosage Form : TABLET; ORAL

Proprietary Name : AMITRIPTYLINE HYDROCHLOR...

Dosage Strength : 25MG

Approval Date : 2023-05-01

Application Number : 215376

RX/OTC/DISCN : RX

RLD : No

TE Code : BX

blank

10

Brand Name : AMITRIPTYLINE HYDROC...

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : AMITRIPTYLINE HYDROC...

PEGS Boston Summit
Not Confirmed
arrow

Rubicon Research

Dosage Form : TABLET; ORAL

Proprietary Name : AMITRIPTYLINE HYDROCHLOR...

Dosage Strength : 50MG

Approval Date : 2023-05-01

Application Number : 215376

RX/OTC/DISCN : RX

RLD : No

TE Code : BX

blank
click full view

Inspections and registrations

Upload your audits for free, ask us

FDA

read-more
read-more

01

FDA Audited

USA
PEGS Boston Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
PEGS Boston Summit
Not Confirmed

Rubicon Research

City : Thane

State :

Country/Area : India

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2025-03-20

blank

02

FDA Audited

USA
PEGS Boston Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
PEGS Boston Summit
Not Confirmed

Rubicon Research

City : Thane

State :

Country/Area : India

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2024-03-08

blank

03

FDA Audited

USA
PEGS Boston Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
PEGS Boston Summit
Not Confirmed

Rubicon Research

City : Concord

State :

Country/Area : Canada

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2023-11-03

blank

04

FDA Audited

USA
PEGS Boston Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
PEGS Boston Summit
Not Confirmed

Rubicon Research

City : Thane

State :

Country/Area : India

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2023-01-27

blank

05

FDA Audited

USA
PEGS Boston Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
PEGS Boston Summit
Not Confirmed

Rubicon Research

City : Concord

State :

Country/Area : Canada

Zip :

District :

Center :

Project Area : Bioresearch Monitoring

District Decision : No Action Indicated

Inspection End Date : 2018-10-18

blank

06

FDA Audited

USA
PEGS Boston Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
PEGS Boston Summit
Not Confirmed

Rubicon Research

City : Thane

State :

Country/Area : India

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2017-11-20

blank

07

FDA Audited

USA
PEGS Boston Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
PEGS Boston Summit
Not Confirmed

Rubicon Research

City : Concord

State :

Country/Area : Canada

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2016-07-27

blank

08

FDA Audited

USA
PEGS Boston Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
PEGS Boston Summit
Not Confirmed

Rubicon Research

City : Thane

State :

Country/Area : India

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2015-03-13

blank

09

FDA Audited

USA
PEGS Boston Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
PEGS Boston Summit
Not Confirmed

Rubicon Research

City : Thane

State :

Country/Area : India

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2013-04-11

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Contact Rubicon Research and get a quotation

Rubicon Research is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find Dextromethorphan bulk with DMF offered by Rubicon Research

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty